CanadaBis Capital Inc. and 1926360 Alberta Ltd. (dba Stigma Pharmaceuticals) in the Final Stages of Proposed Amalgamation
CALGARY, AB / ACCESSWIRE / March 21, 2019 / CanadaBis Capital Inc. "TSXV: CANB.P" ("CanadaBis" or the "Company"), an Alberta...
CALGARY, AB / ACCESSWIRE / March 21, 2019 / CanadaBis Capital Inc. "TSXV: CANB.P" ("CanadaBis" or the "Company"), an Alberta...
HAMBURG, GERMANY / ACCESSWIRE / March 21, 2019 / Evotec AG (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) will report...
BERKELEY HEIGHTS, NJ / ACCESSWIRE / March 21, 2019 / CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on...
Implantations to Take Place by End of April with Initial Data Expected in June 2019 IRVINE, CA / ACCESSWIRE /...
DURHAM, NC / ACCESSWIRE / March 21, 2019 / Heat Biologics, Inc. (NASDAQ: HTBX), a biopharmaceutical company developing immunotherapies designed...
Kuwait Added to the Growing Number of Countries with Approval for ILUVIEN in the Middle East ATLANTA, GA / ACCESSWIRE...